This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of POLIVY 140 MG VIALS, with a ceiling value of $62,725.92 and a period of performance through November 13, 2024. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,046.06 firm fixed-price delivery order is for the supply of POLIVY 140 MG VIALS and has an ultimate completion date of April 23, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $11,023.03, is for the supply of 4567037176 - POLIVY 140 MG VIALS. The contract has an ultimate completion date of February 14, 2025 and is a firm fixed-price delivery order. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,023.03, is for the supply of 4567202138 POLIVY 140 MG VIALS, with an ultimate completion date of March 3, 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The contract, valued at $20,908.66, is for the delivery of POLIVY 140 MG VIALS, a specialty medication, to support various government healthcare programs and facilities. The contract has an ultimate completion date of October 9, 2024, and is a firm fixed-price delivery order. This award is likely part of a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,567,965,365 units of the medication POLIVY 140 MG VIALS. The contract has a ceiling value of $22,046.06 and a performance period ending on May 9, 2025. The contract is a firm fixed-price, non-set-aside delivery order, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor and holds a larger...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $22,046.06, is for the delivery of the pharmaceutical product "POLIVY 140 MG VIALS" with a completion date of May 6, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This is a firm fixed-price delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of POLIVY 140 MG VIALS, a medical product, with a ceiling value of $55,115.15 and a completion date of June 3, 2025. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug...
This is a $10,454.32 Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, part of the U.S. Department of Defense, to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of POLIVY 140 MG VIALS, a pharmaceutical product, with a performance period ending on May 22, 2024. Amerisourcebergen Drug Corp is a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company, and holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $90,574.48 firm fixed-price delivery order is for the supply of POLIVY 140 MG VIALS, a pharmaceutical product. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive global...